|
|
U.S. DNA Microarray MarketsPublished by: Frost & Sullivan Published: Dec. 29, 2005 Table of Contents
1. Executive Summary 2. Total DNA Microarray Markets 3. Arrays Market 4. Consumables Market 5. Instrumentations Market 6. Software Market 7. Decision Support Databases List of Figures SEGMENT 2 SEGMENT 3 SEGMENT 4 SEGMENT 5 SEGMENT 6 AbstractResearch OverviewThis Frost & Sullivan research service entitled U.S. DNA Microarrays Markets thoroughly examine the Arrays Markets, Consumables Markets, Instrumentations Markets, and Software Markets. Benefits of this Service New Market Strategies Address Major DNA Microarrays Market Challenges The DNA microarrays market has been faced with major challenges including, decreased NIH budgets, decreased research focus in genomics, high costs of products and receiving FDA approval. This research targets specific DNA microarrays market challenges and suggests new strategies to overcome the barriers in the market. Thorough Research Analysis Captures Market Share Information Frost & Sullivan research methodology is based on conducting primary interviews, which means speaking directly to top suppliers in the market. This unique research methodology, allows a complete market share analysis to be conducted with trusted information. A thorough analysis on the DNA microarrays market within the United States was completed, breaking up the top competitors in terms of percent of market held by revenue in 2005 for the arrays, software, and instrumentations market segments. Unique Analysis Uncovers New Market Opportunities for Growth The DNA microarrays market within the United States has been growing lucratively in the past few years in various industry sectors. The challenge for DNA microarrays manufacturers is deciding what areas to target for growth opportunities. This research deliverable identifies key opportunities for market penetration providing manufacturers with the opportunity to grow in terms of revenue. Primary Research Identifies New Market and Technology Trends The DNA microarrays market is evolving at an unprecendented rate in all market segments. All market segments have unique market offerings and technological advances, which are discussed in great detail throughout the research deliverable. This will provide manufacturers with the opportunity to learn about the future of DNA microarrays in different industry sectors with respect to the technology and the market. Detailed Revenue Forecasts to Help Manufacturers Develop Future Plans The DNA microarrays market is expected to change over the forecasting period from 2006-2012. Frost & Sullivan’s analyst expertise has strategically predicted the future market, which will enable manufacturers to develop future business strategies to stay competitive in the market place. Market Sectors
Expansion into Niche Markets Heightens Revenue Opportunities Many manufacturers are offering solutions for applications for niche markets that were previously ignored, therefore contributing to an increase in revenues. Microarrays have been applied to the areas of environmental sciences, agriculture research, bio-defense, diagnostics, forensics, pharmacogenomics and toxicogenomics. The new niche market areas have broadened the number applications that microarrays can be used for. As companies continue to address niche market needs, the revenue growth is expected to continue to expand. “DNA microarrays products are quickly becoming integral tools for both pre-clinical and clinical research. Furthermore, the power of microarray technologies is just beginning to be explored in the diagnostics arena, where they will be crucial for making therapeutic decisions.” Gene expression analysis provides information on what is happening in a system at the molecular level. This information is vital to understand the factors that change the system, as well as those that do not. Microarrays have been used in research for almost a decade; however, it is their promise as diagnostics tool that will drive market for these products in the future. The importance of DNA microarrays in research for disease diagnosis, understanding drug interactions and determining drug candidates is expected to keep the market growing substantially. In 2005, revenue for the total U.S. DNA microarrays market totaled approximately $446.8 million and is expected to rise to $532.1million by the end of 2012. The compound annual growth rate (CAGR) for 2005 to 2012 is estimated at 10.9 percent. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||